Strandline Resources
http://www.strandline.com.au/irm/PDF/d07c84cb-a633-412b-ae56-7af79b0e7e99/FosterStockbrokingEquityReportAdvancedDeveloperwithLowCostProjectsPriceTarget032
http://www.strandline.com.au/irm/PDF/8b67f363-56f0-460f-9cb4-6d542e73a8f8/ShawandPartnersEquityReportCoburnstimehasarrivedInitiationofcoveragePriceTarget032
http://www.strandline.com.au/irm/PDF/2762_0/Morgans39InitialEquityResearchReportAGrowthPlan
http://www.strandline.com.au/irm/PDF/2669_0/HartleysResearchReport
http://www.strandline.com.au/irm/showdownloaddoc.aspx?AnnounceGuid=85f95a45-e220-4867-a18b-57af120ddb53&[email protected]
http://www.strandline.com.au/irm/PDF/2328_0/ArgonautResearchReportThreeprongedappealInitiation
http://www.strandline.com.au/irm/content/broker-reports.aspx?RID=481
- Forums
- ASX - General
- Research Reports
Research Reports, page-87
Featured News
Featured News
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online